Statements (67)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:associated_with |
reduced incidence of meningitis
reduced incidence of septicemia |
| gptkbp:can_be |
severe allergic reactions
mild side effects |
| gptkbp:contains |
serogroup B antigens
|
| gptkbp:evaluates |
gptkb:serogroup_B_Neisseria_meningitidis
|
| https://www.w3.org/2000/01/rdf-schema#label |
MenB vaccine
|
| gptkbp:includes |
gptkb:CDC_immunization_schedules
WHO recommendations |
| gptkbp:introduced |
2013
|
| gptkbp:is_a_subject_of |
public awareness campaigns
vaccine_hesitancy |
| gptkbp:is_available_in |
various formulations
|
| gptkbp:is_evaluated_by |
clinical trials
regulatory agencies |
| gptkbp:is_funded_by |
government health programs
|
| gptkbp:is_linked_to |
increased vaccination rates
decreased morbidity decreased mortality |
| gptkbp:is_monitored_by |
safety and efficacy
|
| gptkbp:is_open_to |
2 to 8 degrees Celsius
|
| gptkbp:is_part_of |
public health initiatives
emergency response plans community health programs health education initiatives international health regulations preventive healthcare measures childhood vaccination programs school health programs workplace health programs global health strategies meningococcal vaccination strategy vaccine development research adolescent vaccination programs adult vaccination programs infectious disease control efforts routine immunization schedule travel vaccination recommendations |
| gptkbp:is_promoted_through |
health organizations
intramuscular injection |
| gptkbp:is_recognized_for |
gptkb:European_Union
gptkb:United_States |
| gptkbp:is_studied_in |
long-term immunity
booster doses |
| gptkbp:is_supported_by |
clinical guidelines
scientific research |
| gptkbp:is_used_in |
epidemiological studies
public forums medical literature outbreak control healthcare_settings |
| gptkbp:issueDate |
young adults
adolescents |
| gptkbp:opposedBy |
gptkb:serogroup_W_Neisseria_meningitidis
gptkb:serogroup_C_Neisseria_meningitidis gptkb:serogroup_Y_Neisseria_meningitidis serogroup A Neisseria meningitidis |
| gptkbp:produces |
gptkb:Pfizer
Novartis |
| gptkbp:relatedTo |
other meningococcal vaccines
|
| gptkbp:requires |
two doses
|
| gptkbp:serves |
Meningococcal disease
|
| gptkbp:suitableFor |
high-risk individuals
travelers to endemic areas military recruits college students living in dormitories |